Hans-Christian Kolberg, MD: Biosimilars and Patient Access

August 5, 2019

Hans-Christian Kolberg, MD, head of the department of obstetrics and gynecology, breast cancer center, and gynecologic cancer center at Marienhospital Bottrop, Germany, discusses the impact that biosimilars have made on patient access to therapy.

Transcript

In the developed countries, it’s very hard to say that it has improved; globally, it has improved. In the United States and in Germany, access to trastuzumab was not actually really a problem. In the developing countries, it definitely has improved. I know that from a hospital in China that I’m cooperating with.